Gamma Secretase Inhibitor RO4929097 in Previously Treated Metastatic Pancreas Cancer

Clinical trial NCT01232829 · COMPLETED

Trial details

NCT number: NCT01232829
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma of the Pancreas Recurrent Pancreatic Cancer Stage IV Pancreatic Cancer

Start date: 2010-10-01
Primary completion: 2012-07-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.